Institutional Biosafety Commitee (IBC)

The function of the Institutional Biosafety Committee (IBC) is to ensure that research using recombinant or synthetic DNA, infectious agents, or select agents/toxins is carried out in conformity with federal guidelines. Questions regarding the IBC may be directed to Dr. John Singer,  207.581.2808, jsinger@maine.edu, Chair of the Committee.

IBC Membership: Current membership listing.

Policies and Procedures for Research Involving Recombinant or Synthetic Nucleic Acid Molecules or Infectious Agents (Word)  (Revised May 2017)

Request-Notification Regarding the Use of Recombinant DNA (Word) (print out and send to John Singer, Hitchner Hall)

Request to Use Class 2 or Higher Infectious Agents in Teaching or Research (Word) (print out and send to John Singer, Hitchner Hall)

Required Training:  All faculty, staff, and students involved with the use of recombinant DNA or infectious agents must complete training

Biosafety Checklist (Word) (recommended that BLS2 labs conduct a self-audit on a yearly basis)

 


Contact for Questions

Portrait of Paula PortalatinPaula Portalatin
Research Compliance Officer III
paula.portalatin@maine.edu
207.581.2657, 311 Alumni Hall

 

Portrait of Amanda AsheAmanda Ashe, CRA
Director of Research Compliance
amanda.l.ashe@maine.edu
207.581.1480, 310 Alumni Hall